Drugs for HER-2-positive breast cancer

Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors. With implementation of the growth-inhibitory...

Descripción completa

Detalles Bibliográficos

Publicado en:	Springer eBooks.
Autor Corporativo:	SpringerLink (Online service)
Otros Autores:	Sibilia, Maria, Zielinski, Christoph C., Bartsch, Rupert, Grunt, Thomas W.
Formato:	Electronic Resource
Lenguaje:	English
Publicado:	Basel Springer Basel c2011.
Materias:	Medicine. Oncology. Immunology. Electronic books.
Acceso en línea:	Available for University of the Philippines Diliman via SpringerLink. Click here to access